NCT01538849View on ClinicalTrials.gov

Study to Investigate the Safety, Tolerability and Efficacy of YH4808 in Patients With Reflux Esophagitis

PHASE2CompletedINTERVENTIONAL

Enrollment

154

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

November 30, 2013

Study Completion Date

May 31, 2014

Conditions

Reflux Esophagitis

Interventions

DRUG

Esomeprazole 40mg

1 tablet = Esomeprazole 40 mg

DRUG

YH4808 A mg

1 tablet = YH4808 A mg

DRUG

YH4808 B mg

1 tablet = YH4808 B mg

DRUG

YH4808 C mg

YH4808 C mg = 2 x YH4808 B mg

Trial Locations (1)

137-701

Seoul ST.MARY'S HOSPITAL, Seoul

All Listed Sponsors

lead

Yuhan Corporation

INDUSTRY

NCT01538849 - Study to Investigate the Safety, Tolerability and Efficacy of YH4808 in Patients With Reflux Esophagitis | Biotech Hunter | Biotech Hunter